Status: Recruiting
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.
Participants needed: 276
Trial details
Phase: Phase 4Age: 18-70Biological sex: AllType: InterventionalSponsor: Tongji HospitalUpdated: Feb 1, 2024Locations: 1
Eligibility criteria
18 to 70 years of age; [+3]
Allergic to rapamycin or its derivatives； [+6]